Sign In
Buy DGNOF
$0.158
-0.0041 (-2.54%)
At Close: Jun 03, 2026
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
10:00am, Wednesday, 03'rd Jun 2026
DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. BROSSARD, Quebec, June
DIAGNOS Announces Amendment to Convertible Debentures
07:00pm, Wednesday, 13'th May 2026
BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of crit
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
12:14pm, Wednesday, 08'th Apr 2026
BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of ey
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
11:50am, Wednesday, 01'st Apr 2026
BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of ey
DIAGNOS (OTCMKTS:DGNOF) Trading Up 2.6% – Time to Buy?
02:20am, Thursday, 19'th Mar 2026
Shares of DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report) shot up 2.6% during trading on Wednesday. The stock traded as high as $0.2145 and last traded at $0.2125. 25,000 shares were traded during mid-
DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants
03:45pm, Thursday, 05'th Mar 2026
BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of cr
DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
09:23am, Tuesday, 24'th Feb 2026
BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of cri
DIAGNOS (OTCMKTS:DGNOF) Trading 1.6% Higher – Still a Buy?
02:18am, Wednesday, 18'th Feb 2026
DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report)'s share price traded up 1.6% during trading on Tuesday. The company traded as high as $0.2189 and last traded at $0.2175. 300,800 shares were traded duri
DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
09:30am, Wednesday, 04'th Feb 2026
BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of cr
DIAGNOS Announces the Engagement of IBN
03:30pm, Thursday, 15'th Jan 2026
BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
Head to Head Analysis: DIAGNOS (OTCMKTS:DGNOF) vs. Fathom (NASDAQ:FTHM)
05:12am, Monday, 05'th Jan 2026
Fathom (NASDAQ: FTHM - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the better investment? We will contrast the two compa
Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
01:30pm, Tuesday, 09'th Dec 2025
Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Quebec, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”)
Contrasting DIAGNOS (OTCMKTS:DGNOF) & Priority Technology (NASDAQ:PRTH)
01:48am, Monday, 01'st Dec 2025
Priority Technology (NASDAQ: PRTH - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the t
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
04:15pm, Thursday, 13'th Nov 2025
BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
04:36pm, Monday, 10'th Nov 2025
Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD, Quebec, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”)
